Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 7;14:1217590. doi: 10.3389/fimmu.2023.1217590

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Zeng, Wang, Yang, Chen, Cui, Li, Luo, Ding, Ju, Li, Chen, Xie, Tong, Liu and Zhao

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Correlation between IARGI and TME, mutation levels, chemotherapeutic drug sensitivity. (A) IARGI risk scores in IAG-high and IAG-low patterns; (B) IARGI risk scores in the two different gene subtypes; (C) Stromal score, immune score, and estimate score between high- and low-risk groups; (D) Evaluation of immune cell infiltration in high-risk and low-risk groups by TIMER algorithm; (E) Evaluation of immune cell infiltration in high-risk and low-risk groups by ssGSEA algorithm. (F) TIDE score in high-risk and low-risk groups; (G) Genetic mutation in high-risk and low-risk groups; (H, I) Prediction of chemotherapeutic drugs in high-risk and low-risk groups. *P<0.05, **P<0.01, ***P < 0.001.